Aurora Spine Appoints Executive Vice President of Sales

Aurora Spine Appoints Executive Vice President of Sales 
CARLSBAD, CALIFORNIA -- (Marketwired) -- 02/13/14 --   Aurora Spine
Corporation (TSX VENTURE: ASG) announced today the appointment of
Mike Keegan to the newly created position of Executive Vice
President, U.S. Sales. Mr. Keegan will be responsible for the
Company's U.S. sales efforts, including the oversight of strategic
sales development, sales administration, adding divisional sales
directors and sales training. He will also serve as a member of
Aurora Spine's Executive Management Team.  
Prior to joining Aurora, Mr. Keegan served as Director of U.S. Sales
for Lanx, a designer, manufacturer, and supplier of spinal devices
and biologics. Mr. Keegan has over 25 years of sales and marketing
Mr. Keegan served as Area Director for Globus Medical, District Sales
Manager for Medtronic and held various sales, marketing, management
and international roles with Boston Scientific Corporation. Mr.
Keegan began his sales career with the Xerox Corporation. He has a
proven track record of building dynamic and highly successful sales
teams. He received a B.A. degree from Providence College and an MBA
from Boston University.  
Trent J. Northcutt, President and Chief Executive Officer, said,
"Mike Keegan's experience as a medical sales executive, with a proven
track record to create and lead successful and dynamic sales teams,
will be a tremendous asset to Aurora Spine. We believe his background
and extensive knowledge of the spine industry will allow him to
seamlessly integrate into this new role. Mike will focus on further
strengthening our sales and distribution network as we continue to
make rapid progress on the creation of a hybrid sales force
consisting of direct sales employees and independent distributors. I
am confident that Mike will lead our sales team to maximum
performance in 2014 and beyond." 
About Aurora Spine  
Aurora Spine is an early stage company focused on bringing new
solutions to the spinal implant market through a series of
innovative, minimally invasive, regenerative spinal implant
Forward-Looking Statements  
This news release contains forward-looking information that involves
substantial known and unknown risks and uncertainties, most of which
are beyond the control of Aurora Spine, including, without
limitation, those listed under "Risk Factors" and "Cautionary
Statement Regarding Forward-Looking Information" in Aurora Spine's
final prospectus (collectively, "forward-looking information").
Forward-looking information in this news release includes information
concerning the proposed success of the company's sales efforts.
Aurora Spine cautions investors of Aurora Spine's securities about
important factors that could cause Aurora Spine's actual results to
differ materially from those projected in any forward-looking
statements included in this news release. Any statements that
express, or involve discussions as to, expectations, beliefs, plans,
objectives, assumptions or future events or performance are not
historical facts and may be forward-looking and may involve
estimates, assumptions and uncertainties which could cause actual
results or outcomes to differ unilaterally from those expressed in
such forward-looking statements. No assurance can be given that the
expectations set out herein will prove to be correct and,
accordingly, prospective investors should not place undue reliance on
these forward looking statements. These statements speak only as of
the date of this press release and Aurora Spine does not assume any
obligation to update or revise them to reflect new events or
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004 
Aurora Spine Corporation
Eric Fronk
Chief Financial Officer
(760) 424-2004
Press spacebar to pause and continue. Press esc to stop.